Search Ontology:
ChEBI

beta-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-alpha-D-Galp

Term ID
CHEBI:149145
Synonyms
  • (2R,3S,4R,5S,6S)-2-[(2R,3S,4R,5R,6S)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
  • 6-deoxy-beta-L-galactopyranosyl-(1->4)-[alpha-D-glucopyranosyl-(1->3)]-alpha-D-galactopyranose
  • alpha-D-gluco-hexopyranosyl-(1->3)-[6-deoxy-beta-L-galacto-hexopyranosyl-(1->4)]-alpha-D-galacto-hexopyranose
  • beta-L-fucopyranosyl-(1->4)-[alpha-D-glucopyranosyl-(1->3)]-alpha-D-galactopyranose
  • Glc(a1-3)[Fuc(b1-4)]a-Gal
Definition
A trisaccharide that is α-D-galactopyranose in which the hydroxy groups at positions 3 and 4 have been converted into the corresponding α-D-glucopyranosyl and β-L-fucopyranosyl derivatives, respectively.
References
  • glygen:G28288SL
  • glytoucan:G28288SL
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-alpha-D-Galp
Phenotype where environments contain beta-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-alpha-D-Galp
Phenotype modified by environments containing beta-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-alpha-D-Galp
Phenotype affecting beta-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-alpha-D-Galp
Human Disease Model